BlueRidge Life Sciences (“BlueRidge”), a leading life sciences consulting and services platform and a portfolio company of Renovus Capital Partners, today announced the acquisition of Design Science, ...
There has been a growing trend of reassessing and moving towards a more updated, post-modern portfolio theory (MPT) risk management and portfolio construction process. Traditional MPT portfolio ...
As part of its expansion efforts in the life sciences space in Cambridge, MA, Boston Properties, Inc. BXP recently closed the acquisition of 125 Broadway in Kendall Square. The six-story ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results